Peptide Therapy Providers in Des Moines, Iowa

1 provider found in Des Moines · 1 offer telehealth · 1 free consultations

PeptideProbe lists 1 peptide therapy provider in Des Moines, Iowa. Whether you're researching GLP-1 weight-loss medications like semaglutide and tirzepatide, recovery peptides such as BPC-157, or hormone optimization protocols, you can compare clinics below by services offered, telehealth availability, insurance acceptance, and patient reviews. 1 offers a free initial consultation.

Most-offered peptides in Des Moines: Semaglutide (1), Sermorelin (1), Tirzepatide (1), BPC-157 (1), Ipamorelin (1), GHK-Cu (1).

Des Moines, IA
TelehealthFree Consult
SemaglutideSermorelinTirzepatideBPC-157Ipamorelin+1 more

Iowa IV serves Ankeny, West Des Moines, and Des Moines with medical peptide injections for weight loss, metabolic health, and longevity. They offer free telehealth consultations and statewide shipping

View Profile

Nearby Cities in Iowa

Frequently Asked Questions

Peptide therapy costs in Des Moines, Iowa vary by treatment. Semaglutide typically costs $200-$500/month. Other peptides range from $100-$800/month depending on the specific therapy and provider.

Yes, 1 of 1 providers in Des Moines Des Moines, Iowa offer telehealth services. This allows you to consult with practitioners remotely and have medications shipped directly to you.

Providers in Des Moines commonly offer weight-loss peptides (semaglutide, tirzepatide), recovery peptides (BPC-157, TB-500), anti-aging treatments (NAD+, GHK-Cu), and hormone optimization therapies (sermorelin, CJC-1295).

Yes — peptide therapies in Des Moines require a prescription from a licensed healthcare provider. This includes FDA-approved GLP-1 medications and compounded peptides from licensed pharmacies. All providers listed on PeptideProbe operate under licensed medical supervision.

Medical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.